JO
AMRX icon

John Overdeck’s Amneal Pharmaceuticals AMRX Stock Holding History

John Overdeck’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.04M Sell
233,270
-49,407
-17% -$677K ﹤0.01% 2343
2026
Q1 		$3.51M Sell
282,677
-18,351
-6% -$246K ﹤0.01% 2306
2025
Q4 		$3.79M Buy
301,028
+231,494
+333% +$2.65M 0.01% 1942
2025
Q3 		$696K Buy
69,534
+51,789
+292% +$465K ﹤0.01% 2810
2025
Q2 		$144K Sell
17,745
-149,955
-89% -$1.13M ﹤0.01% 2963
2025
Q1 		$1.41M Buy
+167,700
New +$1.4M ﹤0.01% 1969
2024
Q4 		– Sell
-27,245
Closed -$227K – 3186
2024
Q3 		$227K Sell
27,245
-30,543
-53% -$239K ﹤0.01% 2771
2024
Q2 		$367K Sell
57,788
-59,878
-51% -$380K ﹤0.01% 2512
2024
Q1 		$713K Sell
117,666
-93,503
-44% -$527K ﹤0.01% 2157
2023
Q4 		$1.28M Sell
211,169
-104,590
-33% -$466K ﹤0.01% 1929
2023
Q3 		$1.33M Sell
315,759
-146,027
-32% -$545K ﹤0.01% 1762
2023
Q2 		$1.43M Buy
461,786
+270,593
+142% +$576K ﹤0.01% 1722
2023
Q1 		$266K Sell
191,193
-386,987
-67% -$771K ﹤0.01% 2473
2022
Q4 		$1.15M Buy
+578,180
New +$1.3M ﹤0.01% 1631
2022
Q2 		– Sell
-118,698
Closed -$495K – 2482
2022
Q1 		$495K Sell
118,698
-156,021
-57% -$691K ﹤0.01% 2016
2021
Q4 		$1.32M Sell
274,719
-117,893
-30% -$588K ﹤0.01% 2311
2021
Q3 		$2.1M Buy
392,612
+289,219
+280% +$1.46M ﹤0.01% 1946
2021
Q2 		$529K Sell
103,393
-636,375
-86% -$3.62M ﹤0.01% 3042
2021
Q1 		$4.98M Buy
+739,768
New +$4.1M 0.01% 1049
2020
Q1 		– Sell
-530,067
Closed -$2.56M – 3048
2019
Q4 		$2.56M Sell
530,067
-364,802
-41% -$1.27M 0.01% 1392
2019
Q3 		$2.6M Buy
894,869
+750,923
+522% +$2.62M 0.01% 1221
2019
Q2 		$1.03M Buy
+143,946
New +$1.47M ﹤0.01% 1913

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

John Overdeck's AMRX Position: Q2 2026 in Review

John Overdeck reduced its Amneal Pharmaceuticals (AMRX) stake by 17% in Q2 2026, selling an estimated $677K and leaving 233,270 shares worth $4.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2343.

John Overdeck first reported a position in AMRX in Q2 2019 and has held it in 22 quarters since. The position peaked at $4.98M in Q1 2021. 305 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • John Overdeck held 233,270 shares of Amneal Pharmaceuticals worth $4.04M as of Q2 2026.
  • John Overdeck sold 49,407 Amneal Pharmaceuticals shares in Q2 2026, an estimated $677K.
  • Amneal Pharmaceuticals made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2343 holding.
  • John Overdeck first reported a position in Amneal Pharmaceuticals in Q2 2019 and has held it in 22 quarters since.
  • John Overdeck's Amneal Pharmaceuticals position peaked at $4.98M in Q1 2021.
  • 305 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.